Equities research analysts at Compass Point started coverage on shares of Strawberry Fields REIT (NYSEAMERICAN:STRW – Get Free Report) in a research report issued on Thursday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $14.00 price target on the stock. Compass Point’s price target would suggest a potential upside of 25.00% from the stock’s current price.
Other research analysts also recently issued reports about the company. Janney Montgomery Scott started coverage on Strawberry Fields REIT in a research note on Wednesday, December 18th. They issued a “buy” rating and a $12.50 price target for the company. Wedbush assumed coverage on shares of Strawberry Fields REIT in a research note on Monday, January 6th. They set an “outperform” rating and a $12.00 target price for the company. Finally, Lake Street Capital initiated coverage on shares of Strawberry Fields REIT in a report on Wednesday, January 8th. They issued a “buy” rating and a $13.50 price target on the stock. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $12.40.
Strawberry Fields REIT Trading Up 0.1 %
Insider Buying and Selling at Strawberry Fields REIT
In other Strawberry Fields REIT news, CEO Moishe Gubin acquired 112,347 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were bought at an average price of $10.00 per share, with a total value of $1,123,470.00. Following the transaction, the chief executive officer now directly owns 700,667 shares of the company’s stock, valued at $7,006,670. The trade was a 19.10 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, major shareholder Alyeska Investment Group, L.P. sold 200,000 shares of Strawberry Fields REIT stock in a transaction on Thursday, December 5th. The stock was sold at an average price of $10.25, for a total value of $2,050,000.00. Following the sale, the insider now owns 1,050,000 shares of the company’s stock, valued at approximately $10,762,500. This trade represents a 16.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired 154,547 shares of company stock worth $1,586,276 over the last 90 days. 10.60% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC purchased a new position in Strawberry Fields REIT during the 3rd quarter worth $45,000. Rhumbline Advisers bought a new position in shares of Strawberry Fields REIT during the 2nd quarter worth $57,000. Barclays PLC increased its stake in shares of Strawberry Fields REIT by 302.3% during the third quarter. Barclays PLC now owns 8,697 shares of the company’s stock valued at $110,000 after buying an additional 6,535 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Strawberry Fields REIT by 186.7% in the third quarter. JPMorgan Chase & Co. now owns 9,572 shares of the company’s stock valued at $121,000 after acquiring an additional 6,233 shares in the last quarter. Finally, Duncan Williams Asset Management LLC purchased a new stake in Strawberry Fields REIT in the third quarter worth about $192,000.
About Strawberry Fields REIT
Strawberry Fields REIT, Inc, is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. The Company's portfolio includes 109 healthcare facilities with an aggregate of 12,449 bed, located throughout the states of Arkansas, Illinois, Indiana, Kentucky, Michigan, Ohio, Oklahoma, Tennessee and Texas.
See Also
- Five stocks we like better than Strawberry Fields REIT
- How to buy stock: A step-by-step guide for beginners
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Stock Market Sectors: What Are They and How Many Are There?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- What Are Growth Stocks and Investing in Them
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Strawberry Fields REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strawberry Fields REIT and related companies with MarketBeat.com's FREE daily email newsletter.